Bacterial Syphilis – A Complete Patient‑Focused Guide
Overview
Syphilis is a sexually transmitted infection (STI) caused by the spirochete bacterium Treponema pallidum. It is sometimes called “the great imitator” because its signs and symptoms can mimic many other diseases.
- Who it affects: Anyone who is sexually active can acquire syphilis, but prevalence is highest among men who have sex with men (MSM), people with multiple sexual partners, and individuals living with HIV.
- Global prevalence: According to the World Health Organization (WHO), there were an estimated 6.3 million new cases of syphilis worldwide in 2022, a 15 % increase from 2019, largely driven by rising rates in the Americas and Western Pacific regions.WHO
- U.S. data: The CDC reported 133,945 primary and secondary syphilis cases in 2023, the highest number ever recorded in a single year in the United States.CDC
Syphilis progresses in distinct stages—primary, secondary, latent, and tertiary—each with characteristic clinical features. Early detection and treatment are essential because untreated infection can cause severe organ damage and increase transmission risk.
Symptoms
Symptoms vary by stage and may be absent, especially during the latent phase.
Primary Syphilis (≈3‑4 weeks after exposure)
- Chancre: A painless, firm, round ulcer usually appearing on the genitals, anus, or mouth. It heals spontaneously within 3‑6 weeks.
- Regional lymphadenopathy: Swollen, non‑tender lymph nodes near the chancre site.
Secondary Syphilis (weeks to months after primary lesion)
- Skin rash: Often copper‑colored or reddish‑brown macules/papules that may involve the palms and soles.
- Mucous membrane lesions: Moist, white‑gray patches (condylomata lata) in the genital or anal area.
- Systemic signs: Fever, malaise, sore throat, weight loss, headache, and generalized lymphadenopathy.
- Hair loss: Diffuse, non‑scarring alopecia (often described as “moth‑eaten”).
Latent Syphilis (asymptomatic)
- Positive serology without clinical signs. Early latent (≤12 months) is still infectious; late latent (>12 months) is not.
Tertiary Syphilis (years to decades later)
- Gummatous lesions: Soft, tumor‑like growths that can affect skin, bone, or internal organs.
- Cardiovascular syphilis:
- Aortic aneurysm or aortitis.
- Valve insufficiency.
- Neurosyphilis: Can manifest as meningitis, stroke, psychiatric disease, or tabes dorsalis (degeneration of the dorsal columns causing gait instability and loss of proprioception).
Congenital Syphilis (transmission from mother to fetus)
- Premature birth, low birth weight, hepatosplenomegaly, jaundice, rash, bone abnormalities, or severe neurologic impairment.
Causes and Risk Factors
Syphilis is transmitted through direct contact with a chancre or mucous membrane lesion containing spirochetes.
Primary modes of transmission
- Unprotected vaginal, anal, or oral sex.
- Contact with infected lesions during oral sex.
- Mother‑to‑child transmission during pregnancy or delivery (congenital syphilis).
- Rarely, through blood transfusion or organ transplantation (screened blood products have made this extremely uncommon).
Risk factors
- Having multiple or new sexual partners.
- Men who have sex with men (MSM), especially when HIV‑positive.
- Engaging in condomless sex or sex under the influence of drugs/alcohol.
- History of other STIs (e.g., chlamydia, gonorrhea, herpes).
- Inadequate prenatal care or untreated maternal syphilis.
- Living in areas with limited access to sexual health services.
Diagnosis
Diagnosis relies on a combination of clinical assessment, serologic testing, and, when indicated, direct visualization of the organism.
Serologic tests
- Nontreponemal tests: Rapid Plasma Reagin (RPR) or Venereal Disease Research Laboratory (VDRL) test. Detect antibodies to cardiolipin; useful for screening and monitoring treatment response.
- Treponemal tests: Fluorescent Treponemal Antibody Absorption (FTA‑ABS), Treponema pallidum particle agglutination (TP‑PA), or enzyme immunoassays (EIAs). Confirmatory; remain positive for life.
Current CDC guidelines favor a “reverse sequence” algorithm—starting with a treponemal EIA, followed by a confirmatory treponemal test, and then a nontreponemal test to assess disease activity.CDC
Direct detection (rarely needed)
- Dark‑field microscopy of exudate from a chancre.
- Polymerase Chain Reaction (PCR) on lesion swabs (in research settings).
Additional work‑up for suspected late disease
- Lumbar puncture for cerebrospinal fluid (CSF) analysis if neurosyphilis is suspected.
- Chest X‑ray or CT to evaluate aortitis.
- Imaging (MRI, CT) of bones or soft tissue for gummatous disease.
Treatment Options
Penicillin remains the drug of choice for all stages of syphilis. Alternative regimens are reserved for penicillin‑allergic patients.
First‑line therapy
- Primary, secondary, or early latent (≤12 months): Benzathine penicillin G 2.4 million units IM single dose.
- Late latent (>12 months) or unknown duration: Benzathine penicillin G 2.4 million units IM weekly for 3 weeks (total 7.2 million units).
- Neurosyphilis, ocular syphilis, or tertiary gumma: Aqueous crystalline penicillin G 18‑24 million units/24 h IV continuous infusion or 3‑4 million units IV every 4 h for 10‑14 days.
Alternative regimens (for penicillin allergy)
- Doxycycline 100 mg orally twice daily for 14 days (early syphilis) or 28 days (late latent). Not recommended for pregnant women.
- Ceftriaxone 1‑2 g IV or IM daily for 10‑14 days (used off‑label; limited data).
- Desensitization to penicillin is preferred for pregnant patients and for neurosyphilis.
Follow‑up
- Repeat nontreponemal test (RPR/VDRL) at 6 months (for HIV‑negative) or 3, 6, 12, and 24 months (for HIV‑positive) to confirm serologic decline.
- Pregnant women should have serology checked 4‑6 weeks after treatment and again at delivery.
Lifestyle & supportive measures
- Abstain from sexual activity until treatment is completed and serology shows ≥4‑fold decline.
- Notify all recent sexual partners so they can be tested and treated.
- Increase hydration and rest during IV therapy.
Living with Bacterial Syphilis
While syphilis is curable, coping with the diagnosis can be stressful. Below are practical tips to help you manage daily life.
- Partner communication: Have open, honest conversations. Use a trusted healthcare provider or STI clinic to facilitate partner notification.
- Adherence: Set reminders for medication (especially if on doxycycline) and follow‑up appointments.
- Safe sex practices: Use condoms consistently; consider additional protection (e.g., dental dams) for oral sex.
- Emotional health: Seek counseling or support groups if you feel shame, anxiety, or depression. Many community health centers offer free mental‑health services.
- Pregnancy planning: Discuss syphilis screening early in prenatal care. Timely treatment prevents congenital infection.
- Vaccinations: Stay up‑to‑date on hepatitis B, HPV, and other vaccines to reduce the risk of co‑infections.
Prevention
Prevention hinges on reducing exposure and early detection.
Behavioral strategies
- Consistent condom use (latex or polyurethane) for vaginal and anal sex.
- Limit the number of concurrent sexual partners.
- Avoid sexual contact when you or your partner have visible sores or rashes.
- Undergo regular STI screening—at least annually for sexually active adults, and more frequently (every 3‑6 months) for MSM, people with HIV, or those with multiple partners.
Medical interventions
- Pre‑exposure prophylaxis (PrEP) for HIV reduces overall STI screening frequency but does not prevent syphilis; routine testing remains essential.
- Annual or trimester‑specific syphilis testing during pregnancy.
- Vaccination against hepatitis B and HPV to lower co‑infection risk.
Community and public‑health measures
- Access to free or low‑cost testing at community health centers, Planned Parenthood, or online mail‑order kits.
- Partner notification services offered by health departments.
- Education campaigns targeting high‑risk groups, especially MSM and pregnant women.
Complications
If left untreated, syphilis can lead to serious, irreversible damage.
- Neurosyphilis: Meningitis, stroke, dementia, and loss of coordination.
- Cardiovascular syphilis: Aortic aneurysm, aortic insufficiency, coronary artery ostial stenosis.
- Gummatous disease: Destructive lesions in skin, bone, liver, or other organs.
- Congenital syphilis: Stillbirth, neonatal death, or lifelong disability.
- Increased HIV transmission: Syphilitic ulcers provide an entry point for HIV.
According to the CDC, patients with neurosyphilis have a 10‑15 % risk of permanent neurological deficits even after treatment.CDC
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Sudden severe headache, stiff neck, or fever (possible meningitis).
- Unexplained loss of vision, double vision, or eye pain (ocular syphilis).
- Chest pain, shortness of breath, or sudden weakness in one side of the body (signs of aortic aneurysm or stroke).
- Severe abdominal pain with vomiting (possible gastrointestinal involvement of tertiary disease).
- High fever (≥ 101 °F/38.3 °C) accompanied by a rash that spreads rapidly.
Key Take‑aways
- Syphilis is curable with appropriate antibiotics, most commonly benzathine penicillin G.
- Early stages present with recognizable lesions; however, many people remain asymptomatic, making routine screening essential.
- Untreated infection can lead to life‑threatening complications involving the brain, heart, and other organs.
- Safe‑sex practices, regular testing, and partner notification are the cornerstone of prevention.
- Never hesitate to seek urgent care for neurological, ocular, or cardiovascular symptoms.
For personalized advice, schedule an appointment with your primary care provider or a sexually transmitted infection clinic.
References:
- World Health Organization. Syphilis Fact Sheet. 2023.
- Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2023.
- CDC. Syphilis Treatment Guidelines, 2015 Update.
- Mayo Clinic. Syphilis: Symptoms & Causes. Updated 2024.
- Cleveland Clinic. Syphilis Overview. 2023.
- National Institutes of Health. Neurosyphilis: Clinical Manifestations and Management. 2020.